HOUSTON, Aug. 20, 2025 /PRNewswire/ — Nutex Health Inc. (“Nutex Health” or the “Company”) (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments in 11 states and primary care-centric, risk-bearing physician networks, today disclosed non-reliance on its (i) unaudited condensed consolidated financial statements as of and for… Continue reading NUTEX HEALTH PROVIDES FINANCIAL REPORTING UPDATE
Author: PR Newswire Online News
Cutalong at Tributer Resort’s Golf Clubhouse Grand Opening Marks Milestone for Lake Anna Luxury Living
REEF has already invested over $85 million dollars and plans to invest over $25 million more in the next 18 months, providing the financial strength to advance development and deliver on its long-term vision. By completing these amenity and infrastructure improvements, these foundational investments not only accelerate growth but also position Cutalong as a transformative… Continue reading Cutalong at Tributer Resort’s Golf Clubhouse Grand Opening Marks Milestone for Lake Anna Luxury Living
Viuda Presenta Demanda por Muerte Injusta y Bajo la Ley Dram Shop Después de que Empleado del Bar Fue Asesinado en el Trabajo por un Cliente Ebrio
Law Office of Alex Martinez, PLLC, y Law Firm of Ricardo A. Garcia, PLLC, representan a la viuda del empleado, Cynthia Rodriguez. MCALLEN, Texas, 20 de agosto de 2025 /PRNewswire-HISPANIC PR WIRE/ — La viuda de Juan Nava Hernandez, un empleado de Oak Texas Bar and Grill, ha presentado una demanda por muerte injusta en el… Continue reading Viuda Presenta Demanda por Muerte Injusta y Bajo la Ley Dram Shop Después de que Empleado del Bar Fue Asesinado en el Trabajo por un Cliente Ebrio
FinVolution Group Reports Second Quarter 2025 Unaudited Financial Results
-H1 Transaction Volume reached RMB106.1 billion, up 9.4% year-over-year- -H1 International Transaction Volume reached RMB6.2 billion, up 37.8% year-over-year- -H1 Revenue reached RMB7,059.0 million, up 11.5% year-over-year- -H1 International Revenues reached RMB1,507.2 million, up 30.2% year-over-year and representing 21.4% of total net revenues- SHANGHAI, Aug. 20, 2025 /PRNewswire/ — FinVolution Group (“FinVolution” or the “Company”)… Continue reading FinVolution Group Reports Second Quarter 2025 Unaudited Financial Results
CENTENE CORPORATION RECOMMENDS STOCKHOLDERS REJECT “MINI-TENDER” OFFER FROM TRC CAPITAL INVESTMENT CORPORATION
ST. LOUIS, Aug. 20, 2025 /PRNewswire/ — Centene Corporation (NYSE: CNC) (Centene) announced today that it received notice of an unsolicited “mini-tender” offer from TRC Capital Investment Corporation (TRC) dated August 5th, 2025. Centene is in no way affiliated with TRC. TRC has offered to purchase up to 4 million shares of Centene’s common stock at… Continue reading CENTENE CORPORATION RECOMMENDS STOCKHOLDERS REJECT “MINI-TENDER” OFFER FROM TRC CAPITAL INVESTMENT CORPORATION
KASOWITZ LLP: ENVESTNET, INC. WAS FOUND TO HAVE ACTIVELY PARTICIPATED IN SPOLIATION AND NOW FACES A DELAWARE JURY TRIAL ON FINANCIALAPPS’ $100 MILLION TRADE SECRET MISAPPROPRIATION CLAIM
NEW YORK, Aug. 20, 2025 /PRNewswire/ — Six years into a $100 million lawsuit brought by Kasowitz LLP on behalf of fintech pioneer FinancialApps, LLC against defendants Envestnet, Inc. and Yodlee, Inc. for trade secret misappropriation, tortious interference, and unfair competition, a Special Master appointed by the Delaware District Court has recommended formal sanctions against both Envestnet (recently acquired… Continue reading KASOWITZ LLP: ENVESTNET, INC. WAS FOUND TO HAVE ACTIVELY PARTICIPATED IN SPOLIATION AND NOW FACES A DELAWARE JURY TRIAL ON FINANCIALAPPS’ $100 MILLION TRADE SECRET MISAPPROPRIATION CLAIM
Global Minimal Residual Disease Testing Market Gearing Up for Outstanding Expansion at a CAGR of ~11% by 2032 | DelveInsight
The demand for minimal residual disease testing is increasing mainly due to the higher prevalence of solid tumors and blood cancers like leukemia, multiple myeloma, and lymphoma. Continuous advances in molecular diagnostics have greatly improved MRD detection accuracy, and active product development and launches by leading companies are further boosting the market’s momentum. LAS VEGAS,… Continue reading Global Minimal Residual Disease Testing Market Gearing Up for Outstanding Expansion at a CAGR of ~11% by 2032 | DelveInsight
CTO Realty Growth, Inc. Stockholders with Large Losses Should Contact Robbins LLP for Information About Leading the CTO Class Action
SAN DIEGO, Aug. 20, 2025 /PRNewswire/ — Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired CTO Realty Growth, Inc. (NYSE: CTO) securities between February 18, 2021 and June 24, 2025. CTO is a publicly traded real estate investment trust (“REIT“) that owns and operates a… Continue reading CTO Realty Growth, Inc. Stockholders with Large Losses Should Contact Robbins LLP for Information About Leading the CTO Class Action
Biohaven Ltd. Stockholders are Urged to Seek Representation to Lead the BHVN Class Action: Contact Robbins LLP for More Information
SAN DIEGO, Aug. 20, 2025 /PRNewswire/ — Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Biohaven Ltd. (NYSE: BHVN) securities between March 24, 2023 and May 14, 2025. Biohaven is a biopharmaceutical company that discovers, develops, and commercializes therapies for immunology, neuroscience, and oncology. The… Continue reading Biohaven Ltd. Stockholders are Urged to Seek Representation to Lead the BHVN Class Action: Contact Robbins LLP for More Information
ALT STOCK: Robbins LLP Reminds ALT Stockholders of the Opportunity to Lead the Class Action Lawsuit Against Altimmune, Inc.
SAN DIEGO, Aug. 20, 2025 /PRNewswire/ — Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Altimmune, Inc. (NASDAQ: ALT) securities between August 10, 2023 and June 25, 2025. Altimmune is a clinical stage biopharmaceutical company focused on developing treatments for obesity, metabolic and liver diseases.… Continue reading ALT STOCK: Robbins LLP Reminds ALT Stockholders of the Opportunity to Lead the Class Action Lawsuit Against Altimmune, Inc.